Drug intelligence / Profile preview

4-[(Isopropylamino)Methyl]Phenylalanine

Development stage
Unknown
Modality
Small Molecules
01

Overview

4-[(Isopropylamino)Methyl]Phenylalanine is a synthetic derivative of the amino acid phenylalanine, featuring an isopropylamino group attached to the para position of the phenyl ring. This modification distinguishes it from natural phenylalanine and other derivatives. The compound has a molecular formula of C13H20N2O2 and a molecular weight of approximately 236.31 g/mol[1][5]. It is classified as a small molecule and has been primarily studied in experimental settings rather than clinical use[3]. Research suggests that this compound may modulate neurotransmitter pathways due to its structural similarity to phenylalanine, which is involved in dopamine and norepinephrine synthesis. Its unique substitution pattern could enhance biological activity or therapeutic potential for neurological disorders, but there are no approved indications or advanced clinical trials reported for this molecule[5].

Other names
4-isopropylaminomethyl-L-phenylalanine(2S)-2-amino-3-(4-{[(propan-2-yl)amino]methyl}phenyl)propanoic acid4-[[(1-methylethyl)amino]methyl]-L-phenylalanine

Beyond the preview

Go deeper on 4-[(Isopropylamino)Methyl]Phenylalanine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-[(Isopropylamino)Methyl]Phenylalanine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call